CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients.

Item

http://www.wikidata.org/entity/Q36234164

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

CYP3A5 and ABCB1 genotype infl ...... n renal transplant recipients.

@ast

CYP3A5 and ABCB1 genotype infl ...... n renal transplant recipients.

@en

type

Item

label

CYP3A5 and ABCB1 genotype infl ...... n renal transplant recipients.

@ast

CYP3A5 and ABCB1 genotype infl ...... n renal transplant recipients.

@en

prefLabel

CYP3A5 and ABCB1 genotype infl ...... n renal transplant recipients.

@ast

CYP3A5 and ABCB1 genotype infl ...... n renal transplant recipients.

@en

P1476

CYP3A5 and ABCB1 genotype infl ...... n renal transplant recipients.

@en

P2093

Jiangtao Tang

http://www.w3.org/2001/XMLSchema#string

Lanlan Wang

http://www.w3.org/2001/XMLSchema#string

Lin Yan

http://www.w3.org/2001/XMLSchema#string

Yangjuan Bai

http://www.w3.org/2001/XMLSchema#string

Yi Li

http://www.w3.org/2001/XMLSchema#string

Yunying Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo.

Pharmacogenomics--drug disposition, drug targets, and side effects.

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.

Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.

Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks.

The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1).

Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.

Genetic polymorphisms and individualized tacrolimus dosing.

Simulation of sirolimus exposures and population variability immediately post renal transplantation: importance of the patient's CYP3A5 genotype in tailoring treatment.

P2888

s40064-015-1425-5

P304

637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-015-1425-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283543568

http://www.w3.org/2001/XMLSchema#string

P6179

1050927536

http://www.w3.org/2001/XMLSchema#string

P698

26543771

http://www.w3.org/2001/XMLSchema#string

P932

4628029

http://www.w3.org/2001/XMLSchema#string